Aptose Biosciences Stock Price History
APTO Stock | USD 0.18 0.01 5.26% |
Below is the normalized historical share price chart for Aptose Biosciences extending back to March 16, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aptose Biosciences stands at 0.18, as last reported on the 26th of November, with the highest price reaching 0.19 and the lowest price hitting 0.16 during the day.
If you're considering investing in Aptose Stock, it is important to understand the factors that can impact its price. Aptose Biosciences secures Sharpe Ratio (or Efficiency) of -0.21, which signifies that the company had a -0.21% return per unit of risk over the last 3 months. Aptose Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aptose Biosciences' Standard Deviation of 5.38, risk adjusted performance of (0.13), and Mean Deviation of 3.58 to double-check the risk estimate we provide.
At this time, Aptose Biosciences' Common Stock Shares Outstanding is very stable compared to the past year. As of the 26th of November 2024, Other Stockholder Equity is likely to grow to about 75.8 M, though Total Stockholder Equity is likely to grow to (2.8 M). . As of the 26th of November 2024, Price To Sales Ratio is likely to drop to 12.36. In addition to that, Price Earnings Ratio is likely to drop to -0.35. Aptose Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of October 2014 | 200 Day MA 0.8837 | 50 Day MA 0.3756 | Beta 1.364 |
Aptose |
Sharpe Ratio = -0.2077
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | APTO |
Estimated Market Risk
5.47 actual daily | 48 52% of assets are more volatile |
Expected Return
-1.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aptose Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptose Biosciences by adding Aptose Biosciences to a well-diversified portfolio.
Price Book 67.8375 | Book Value (0.36) | Enterprise Value -3.7 M | Enterprise Value Ebitda 0.0496 | Shares Float 11.6 M |
Aptose Biosciences Stock Price History Chart
There are several ways to analyze Aptose Stock price data. The simplest method is using a basic Aptose candlestick price chart, which shows Aptose Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | August 30, 2024 | 0.41 |
Lowest Price | November 25, 2024 | 0.18 |
Aptose Biosciences November 26, 2024 Stock Price Synopsis
Various analyses of Aptose Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aptose Stock. It can be used to describe the percentage change in the price of Aptose Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aptose Stock.Aptose Biosciences Accumulation Distribution | 179,683 | |
Aptose Biosciences Price Rate Of Daily Change | 0.95 | |
Aptose Biosciences Price Daily Balance Of Power | (0.33) |
Aptose Biosciences November 26, 2024 Stock Price Analysis
Aptose Stock Price History Data
The price series of Aptose Biosciences for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.22 with a coefficient of variation of 9.79. The prices are distributed with arithmetic mean of 0.38. The median price for the last 90 days is 0.39. The company had 1:12 stock split on 6th of October 2014.Open | High | Low | Close | Volume | ||
11/25/2024 | 0.18 | 0.19 | 0.16 | 0.18 | 1,137,991 | |
11/22/2024 | 0.14 | 0.19 | 0.13 | 0.19 | 12,076,398 | |
11/21/2024 | 0.30 | 0.30 | 0.23 | 0.24 | 806,452 | |
11/20/2024 | 0.32 | 0.33 | 0.27 | 0.27 | 1,211,576 | |
11/19/2024 | 0.34 | 0.37 | 0.34 | 0.36 | 304,405 | |
11/18/2024 | 0.39 | 0.39 | 0.34 | 0.34 | 448,484 | |
11/15/2024 | 0.37 | 0.39 | 0.36 | 0.36 | 94,087 | |
11/14/2024 | 0.39 | 0.39 | 0.37 | 0.39 | 52,467 | |
11/13/2024 | 0.41 | 0.41 | 0.38 | 0.38 | 44,336 | |
11/12/2024 | 0.40 | 0.40 | 0.38 | 0.39 | 57,258 | |
11/11/2024 | 0.42 | 0.42 | 0.38 | 0.38 | 122,601 | |
11/08/2024 | 0.40 | 0.40 | 0.38 | 0.39 | 92,222 | |
11/07/2024 | 0.39 | 0.40 | 0.38 | 0.39 | 70,754 | |
11/06/2024 | 0.40 | 0.40 | 0.38 | 0.40 | 82,619 | |
11/05/2024 | 0.40 | 0.40 | 0.38 | 0.38 | 20,889 | |
11/04/2024 | 0.39 | 0.40 | 0.37 | 0.40 | 48,244 | |
11/01/2024 | 0.37 | 0.38 | 0.37 | 0.38 | 48,924 | |
10/31/2024 | 0.37 | 0.39 | 0.37 | 0.38 | 68,903 | |
10/30/2024 | 0.38 | 0.39 | 0.37 | 0.39 | 47,592 | |
10/29/2024 | 0.37 | 0.39 | 0.36 | 0.39 | 55,611 | |
10/28/2024 | 0.38 | 0.39 | 0.36 | 0.37 | 82,470 | |
10/25/2024 | 0.37 | 0.40 | 0.37 | 0.39 | 39,168 | |
10/24/2024 | 0.40 | 0.40 | 0.37 | 0.39 | 35,321 | |
10/23/2024 | 0.39 | 0.41 | 0.38 | 0.40 | 83,881 | |
10/22/2024 | 0.39 | 0.41 | 0.37 | 0.40 | 154,925 | |
10/21/2024 | 0.37 | 0.39 | 0.36 | 0.39 | 110,784 | |
10/18/2024 | 0.36 | 0.40 | 0.36 | 0.36 | 150,672 | |
10/17/2024 | 0.36 | 0.38 | 0.36 | 0.36 | 82,994 | |
10/16/2024 | 0.35 | 0.37 | 0.35 | 0.37 | 43,520 | |
10/15/2024 | 0.37 | 0.38 | 0.35 | 0.36 | 107,582 | |
10/14/2024 | 0.37 | 0.38 | 0.37 | 0.38 | 29,058 | |
10/11/2024 | 0.35 | 0.38 | 0.35 | 0.37 | 57,236 | |
10/10/2024 | 0.36 | 0.37 | 0.36 | 0.37 | 22,487 | |
10/09/2024 | 0.37 | 0.37 | 0.35 | 0.37 | 24,596 | |
10/08/2024 | 0.36 | 0.37 | 0.34 | 0.36 | 72,218 | |
10/07/2024 | 0.37 | 0.37 | 0.35 | 0.36 | 90,873 | |
10/04/2024 | 0.38 | 0.39 | 0.36 | 0.37 | 39,945 | |
10/03/2024 | 0.40 | 0.40 | 0.37 | 0.39 | 80,636 | |
10/02/2024 | 0.40 | 0.41 | 0.39 | 0.40 | 35,337 | |
10/01/2024 | 0.41 | 0.41 | 0.40 | 0.40 | 52,574 | |
09/30/2024 | 0.41 | 0.42 | 0.40 | 0.41 | 52,766 | |
09/27/2024 | 0.39 | 0.42 | 0.39 | 0.41 | 158,821 | |
09/26/2024 | 0.40 | 0.41 | 0.39 | 0.40 | 53,123 | |
09/25/2024 | 0.41 | 0.42 | 0.33 | 0.41 | 168,150 | |
09/24/2024 | 0.41 | 0.41 | 0.40 | 0.40 | 33,853 | |
09/23/2024 | 0.38 | 0.41 | 0.38 | 0.41 | 75,863 | |
09/20/2024 | 0.40 | 0.42 | 0.39 | 0.40 | 74,465 | |
09/19/2024 | 0.41 | 0.43 | 0.39 | 0.40 | 214,490 | |
09/18/2024 | 0.41 | 0.41 | 0.39 | 0.41 | 169,460 | |
09/17/2024 | 0.37 | 0.41 | 0.37 | 0.40 | 203,991 | |
09/16/2024 | 0.37 | 0.40 | 0.37 | 0.37 | 115,954 | |
09/13/2024 | 0.35 | 0.37 | 0.35 | 0.37 | 187,738 | |
09/12/2024 | 0.37 | 0.37 | 0.35 | 0.36 | 215,981 | |
09/11/2024 | 0.36 | 0.37 | 0.35 | 0.37 | 218,813 | |
09/10/2024 | 0.35 | 0.37 | 0.33 | 0.36 | 158,709 | |
09/09/2024 | 0.35 | 0.36 | 0.34 | 0.35 | 401,608 | |
09/06/2024 | 0.38 | 0.39 | 0.34 | 0.36 | 362,845 | |
09/05/2024 | 0.39 | 0.41 | 0.37 | 0.38 | 1,044,274 | |
09/04/2024 | 0.38 | 0.42 | 0.36 | 0.38 | 1,175,727 | |
09/03/2024 | 0.47 | 0.48 | 0.35 | 0.41 | 18,708,300 | |
08/30/2024 | 0.40 | 0.41 | 0.38 | 0.41 | 6,352,646 |
About Aptose Biosciences Stock history
Aptose Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aptose is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aptose Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aptose Biosciences stock prices may prove useful in developing a viable investing in Aptose Biosciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 6.8 M | 7.1 M | |
Net Loss | -37.6 M | -35.8 M |
Aptose Biosciences Stock Technical Analysis
Aptose Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Aptose Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aptose Biosciences' price direction in advance. Along with the technical and fundamental analysis of Aptose Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aptose to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.13) | |||
Jensen Alpha | (0.88) | |||
Total Risk Alpha | (1.82) | |||
Treynor Ratio | 1.3 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Return On Assets (1.36) | Return On Equity (6.94) |
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.